Search

everythinglearnresearchcommunity

for

Search:↓

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Desmoglein 3 organization in cell connections changes without calcium, affecting cell adhesion.

Low-dose UVB light improves hair growth effects of certain stem cells by increasing reactive oxygen species.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Mice without Vitamin D receptors have hair growth problems because of issues in the hedgehog signaling pathway.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

Low vitamin D levels are common in people with Alopecia Areata.

Scientists identified a group of human skin cells with high growth and regeneration potential.

The hair test for vitamin D could be a useful alternative to blood tests, providing a longer-term vitamin D status, but more research is needed.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Vitamin D boosts a specific protein in skin cells linked to hair follicles.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.